RATIONALE: Activated group 2 innate lymphoid cells (ILC2) produce large amounts of IL-5 and IL-13, and are activated by epithelial derived cytokines including thymic stromal lymphopoietin (TSLP) in response to protease containing antigens. We hypothesized that the airway/lung expression of TSLP and the number of lung IL-5/IL-13 producing ILC2 is dependent upon the host genetic background in mice. METHODS: We challenged A/J, C57BL/6J, and 129S1/SvImJ mice intranasally with 5mg of an extract of Alternaria alternata, a common aeroallergen, and measured TSLP via ELISA in the BAL fluid and lung 6 hours later, during the peak of TSLP expression. We also challenged the same strains of mice for 4 consecutive days with 5mg Alternaria extract and 24 hours after the last challenge we isolated and quantified IL-5/IL-13 producing ILC2 from the lungs via flow cytometry. RESULTS: 129S1/SvImJ mice had a statistically significant 2-fold greater airway and lung TSLP expression compared to mice from A/J and C57BL/ 6J, and 129S1/SvImJ mice have significantly higher numbers of IL-5/IL-13 cytokine producing ILC2 compared to C57BL/6J mice. Further, the number of ILC2 number was approximately 5 times higher for 129S1/ SvImJ than C57BL/6J mice. CONCLUSIONS: These mouse strain differences in airway and lung TSLP expression and IL-5/IL-13 producing ILC2 suggest that QTL (quantitative trait loci) analysis will map genomic loci relevant to important features of the allergen-induced innate immune response.
Krzysztof Kowal, MD PhD, Agnieszka Pampuch, Ewa Sacharzewska, and Otylia Kowal-Bielecka; Medical University of Bialystok, Bialystok, Poland. RATIONALE: Tumor necrosis factor family member 14 (TNFSF14/ LIGHT) plays a role in the process of airway remodeling and its effects are regulated by decoy receptors DcR3 and HVEM. Our previous study demonstrated that TNFSF14/LIGHT concentration is elevated in asthmatic patients. The aim of this study was to evaluate serum concentration of DcR3 and HVEM in asthmatic patients. METHODS: Serum samples were obtained from 42 asthmatic patients (A), including 28 controlled on inhaled corticosteroids (AICS) and 14 during asthma exacerbation before systemic corticosteroids therapy (AEX). In the latter group serum samples were also obtained during remission while still on oral corticosteroids (AOCS). In addition, 12 allergic rhinitis patients (AR) and 24 healthy controls were included (HC). Concentration of DcR3 and HVEM was evaluated using ELISA method. RESULTS: The mean concentration of DcR3 and HVEM did not differ significantly between A and AR (p>0.05 for both), both being significantly greater than in HC (p<0.01 for each comparison). Among asthmatic patients serum concentration of DcR3 was significantly greater in AEX than in AICS (p<0.001) both being significantly greater than in HC (p<0.001 1 National Jewish Health, Denver, CO, 2 Natl. Jewish Health, Denver, CO. RATIONALE: Children with asthma who have concurrent tracheobronchomalacia (TBM) often require additional treatments to assist with airway clearance during an exacerbation. Current diagnostic methods for TBM are invasive and effort-dependent, ie. bronchoscopy and dynamic CT scan with forced expiration. We hypothesized that impulse oscillometry (IOS), a noninvasive and effort-independent modality to measure airway resistance and tone may be useful in diagnosing tracheobronchomalacia in children with asthma. METHODS: A retrospective chart review of 44 pediatric patients with asthma, ages 0-21 who underwent IOS from January 2012-July 2017 was performed. Patients with TBM (N56/44) were diagnosed by bronchoscopy, the gold standard. Exclusion criteria included patients whose TBM was suspected by pulmonary function testing alone, patients with congenital malformations and patients unable to complete IOS. A logistic regression analysis was performed to determine the predictive value of different IOS-derived parameters in the diagnosis of TBM. RESULTS: The combination of reactance (i.e. airway tone) in small and large airways at 5Hz (X5) > -1.16 and in large airways at 25Hz (X25) > 0.52 provided an area under the curve of 0.92 (p5 0.01) for distinguishing children with asthma with bronchoscopy-diagnosed TBM. This cut-off level provided 67% sensitivity and 95% specificity and a positive predictive value of 67% with a negative predictive value of 95%. CONCLUSIONS: Measurement of airway tone by IOS may provide a diagnostic alternative for diagnosing TBM in pediatric patients with asthma.
